Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Nrc Health (NRC) Shares Outstanding (2016 - 2026)

Nrc Health's Shares Outstanding history spans 16 years, with the latest figure at $32.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 38.48% to $32.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.0 million, a 38.48% increase, with the full-year FY2025 number at $32.0 million, up 38.48% from a year prior.
  • Shares Outstanding hit $22.6 million in Q4 2025 for Nrc Health, down from $32.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for NRC hit a ceiling of $32.0 million in Q3 2025 and a floor of $22.6 million in Q4 2025.
  • Historically, Shares Outstanding has averaged $25.7 million across 5 years, with a median of $24.7 million in 2022.
  • Biggest five-year swings in Shares Outstanding: fell 16.99% in 2021 and later soared 38.48% in 2025.
  • Tracing NRC's Shares Outstanding over 5 years: stood at $25.4 million in 2021, then dropped by 2.89% to $24.6 million in 2022, then decreased by 1.66% to $24.2 million in 2023, then fell by 4.69% to $23.1 million in 2024, then surged by 38.48% to $32.0 million in 2025.
  • Business Quant data shows Shares Outstanding for NRC at $32.0 million in Q4 2025, $22.7 million in Q3 2025, and $31.8 million in Q2 2025.